Enhanced Centralized Monitoring with Precision

Increase data integrity with our centralized monitoring and scientific data review experts.

By harnessing advanced analytics and a unique review approach designed to support high quality data cross functionally, our Centralized Monitoring team turns complex trial data into actionable insights, ensuring your research is guided by clarity and precision. Discover how our expertise in data integration, analysis, and interpretation can streamline your clinical journey, enhancing efficiency and accelerating your path to success.

Integrated data review enhanced with therapeutic insights

Precision's Centralized Monitoring team stands as a guardian of scientific rigor in clinical trials, applying therapeutic-specific standards to enhance data fidelity. Our team's nuanced approach to complex data review transcends traditional checks, providing an ongoing, holistic analysis that standard aggregate review processes cannot achieve. By interweaving centralized scientific expertise within an integrated data review process to support the multidisciplinary team, Precision preemptively identifies and mitigates risks, protecting data quality, supporting timelines and facilitating informed decision-making throughout the study lifecycle.

Adherence to therapeutic-specific guidelines and standards like RECIST v1.1, iRECIST, itRECIST, IMWG, Lugano, etc. for accuracy in data interpretation.
Study wide consistency in adverse event reporting and compliance to CTCAE criteria.
Manual scrutiny of intricate data sets, catching nuances beyond the scope of programmed DM edit checks.
Proactive detection of complex data quality issues and site concerns, averting potential risks.
Collaborative efforts across Medical, Data Management, Biostatistics, Medical Writing, Clinical and Project Management teams to maintain data integrity.
Mastery in utilizing real-time data analytics to drive quality outcomes and support pivotal trial decisions.

The Centralized Monitoring team at Precision for Medicine is not only defined by its cutting-edge solutions but also by the depth of its therapeutic experience. With years of research and clinical expertise, our global team consistently delivers with the commitment and knowledge that sets Precision apart in the industry.

20 Avg. years research experience

15 Avg. years oncology experience

20 Global team members

8 Avg. years with Precision

Centralized monitoring’s impact from start-up to close-out

Embark on a guided tour of Precision’s Centralized Monitoring team’s support throughout your study’s lifecycle. As part of our Integrated Data Review process, each stage, from start-up to database lock, is fortified with strategic data review and analysis supported by bespoke data visualization tools designed to navigate the intricacies of clinical data and leverage our team’s therapeutic expertise to your benefit. Engage with the interactive content that illustrates how Precision’s dedicated support enhances each pivotal stage, culminating in data-rich insights that illuminate your path to the next phase of development or submission.

Start-Up

Start-Up

Lay the Groundwork for Data Precision

CSAI's engagement begins with providing clinical and scientific expertise to the EDC build and associated study procedure manuals, ensuring that the study starts on solid ground with a focus on data capture aligned to the indication, protocol requirements and future analysis.
Conduct

Conduct

Centralized, Holistic, Scientific Review Navigating Complexity During Conduct

Data review & visualization tools designed to support the conduct of centralized, holistic, scientific data review in real time like Smart Patient Profiles™ and All Patient Data Workbook come into play, offering critical insights for informed decision-making. Our scientific data review approach is the “secret ingredient” within our Integrated Data Review process specifically designed to address the industry gaps that result in inefficient monitoring visits and the late identification of complex issues that cannot be observed with the standard aggregate data cleaning approach or CRA form-by-form SDV but are significantly impactful to overall data quality, timelines and frustrating to study sites. Rigorous risk assessment & mitigation strategies are implemented, alongside team support & training to uphold data integrity.
Precision’s Patient Review Tracker enables efficient monitoring of data trends and metrics.
Lock

Lock

Securing Data Integrity at Database Lock

Holistic, centralized, full patient profile reviews verify data accuracy throughout study conduct supporting on time locking of the database. Early and ongoing review at the patient level centrally, prevents the late identification of complex data issues that may also impact source document verification resulting in the need for additional monitoring visits and timeline delays. Final Medical Review, which is pivotal for study conclusions and regulatory submissions, is a streamlined process with Precision’s Centralized Monitoring team.
Precision Difference

Precision Difference

The Precision Edge in Data Excellence

By the time you reach database lock, our team’s support has helped ensure that your study is finalized with cleaner data and deeper insights, setting the stage for a smoother transition to the next phase of your drug's development journey.

Precision CSAI's Smart Patient Profiles clearly are the result of a lot of effort. They are certainly an extremely helpful tool to monitor patient data.

— Medical Director, Small Biotech
Precision's use of Smart Patient Profiles projects patient data to support informed decision-making. We have found them to be instrumental.

— Project Manager, Midsized Biotech
Precision is part of our team. They put in long days and hard work to help us create the slide deck that allowed our study to move forward. We are so appreciative of how fast they worked.

— Senior Manager, Clinical Trials, Midsized Biotech
Precision's use of Smart Patient Profiles projects patient data to support informed decision-making. We have found them to be instrumental.

— Project Manager, Midsized Biotech

Insights from Precision’s experts

Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate early and late phase development.

Explore our blog

Clinical Trials - Early Phase Research

2025 Biotech Economics: CROs, Advanced Therapies & Trends in Funding

Mar 03, ‘25 | 11 min read

Rob Maiale

Discover

Clinical Trials - Regulatory

FDA's Project Optimus: What Pharma and Biotech Need to Know

Feb 25, ‘25 | 8 min read

Harpreet Singh, MD

Discover

Case Study: Concurrent Phase 1 Solid Tumor Drug Development Successes

Feb 24, ‘25 | 4 min read

has not third author: true, (SizeLimitingPyMap: {main={hs_id=185838258545, hs_child_table_id=0, hs_updated_at=1738849388884, hs_published_at=1741014119284, description=Anna Rodecki is a results driven leader with 24 years of experience in clinical research across the pharmaceutical, device, and biotech industries. She has played a pivotal role in  shaping clinical development plans on both Sponsor and CRO, successfully supporting First- In-Human (FIH) – Phase IV trials successfully across various therapeutics areas.    Anan thrives on building strong, collaborative teams fostering innovation. Her expertise spans strategic planning, risk management, inspection readiness and cross-functional leadership – always with a focus on improving patient outcomes and advancing the future of medicine., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Anna%20Rodecki.png',altText='Anna Rodecki',fileId=185842773784}, lastname=Rodecki, hs_initial_published_at=1738849393727, hs_created_by_user_id=26433386, hs_created_at=1738849349748, hs_is_edited=false, hs_deleted_at=0, name=Anna, job=Director, Project Management, slug=anna-rodecki, hs_updated_by_user_id=26433386}, second={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1741014119284, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=26433386}, third={}})

Anna R.
Kurt P.

Discover

Delivering Clinical Success Across Phases

Clinical Development Strategy

Unlock the full potential of your clinical trials with our tailored Clinical Development Strategies. Designed to navigate the complexities of trial execution, Precision can propel your program toward accelerated success.
Services Offered:
- Clinical Development Planning
- Clinical Trial Design
- Biomarker Trial Strategies
- Basket, Master & Umbrella trials
→LEARN MORE
Full-Service CRO

Experience seamless integration and meticulous management of your clinical trial with our Full-Service CRO. We ensure every detail is managed with expertise to drive your study towards its successful completion.
Services include, but are not limited to:
- Full-service Study Management
- Study Start-up & Feasibility
- Clinical Monitoring
- Medical Monitoring
- Drug Safety & Pharmacovigilance
- Data Management
- Biostatistics
→LEARN MORE
Precision FSP

Amplify your clinical trial efficiency with Precision’s Functional Service Provider (FSP) solutions, offering specialized support focused on your project's unique needs.
Solutions Offered:
- FSP Clinical Monitoring
- FSP Drug Safety & Pharmacovigilance
- FSP Data Management
- FSP Biostatistics
- FSP Statistical Programming
- FSP Medical Writing
→LEARN MORE

Advance therapeutic breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.

Oncology Explore

Rare diseases Explore

Autoimmune Explore

Gene Therapy Explore

Cell Therapy Explore

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

Discover Explore

Global CRO
Services

Award-winning CRO with deep oncology and rare disease expertise

Explore
Discover Explore

Global Laboratory
Services

Exceptional translational and biomarker sciences with global central lab services

Explore
Discover Explore

Manufacturing
Solutions

Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

Explore